These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 38069088)

  • 1. The Role of Immune Dysfunction in Parkinson's Disease Development.
    Cossu D; Hatano T; Hattori N
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
    Harms AS; Ferreira SA; Romero-Ramos M
    Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.
    Contaldi E; Magistrelli L; Comi C
    Handb Clin Neurol; 2023; 193():67-93. PubMed ID: 36803824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
    Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
    Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease.
    Jackson A; Engen PA; Forsyth CB; Shaikh M; Naqib A; Wilber S; Frausto DM; Raeisi S; Green SJ; Bradaric BD; Persons AL; Voigt RM; Keshavarzian A
    Front Neurol; 2022; 13():882628. PubMed ID: 35665034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
    Gorecki AM; Anyaegbu CC; Anderton RS
    Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
    Bartl M; Xylaki M; Bähr M; Weber S; Trenkwalder C; Mollenhauer B
    Neurobiol Dis; 2022 Aug; 170():105744. PubMed ID: 35513230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cells in the pathogenesis of Parkinson's disease.
    Chen Z; Chen S; Liu J
    Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop.
    Arena G; Sharma K; Agyeah G; Krüger R; Grünewald A; Fitzgerald JC
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):427-440. PubMed ID: 35674870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological aspects of Parkinson's disease].
    Belova OV; Arefieva TI; Moskvina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(2):110-119. PubMed ID: 32307420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation.
    Silva DF; Empadinhas N; Cardoso SM; Esteves AR
    Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria.
    Esteves AR; Munoz-Pinto MF; Nunes-Costa D; Candeias E; Silva DF; Magalhães JD; Pereira-Santos AR; Ferreira IL; Alarico S; Tiago I; Empadinhas N; Cardoso SM
    Gut; 2023 Jan; 72(1):73-89. PubMed ID: 34836918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease.
    Tan JSY; Chao YX; Rötzschke O; Tan EK
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.